Pharmacokinetics of Daunorubicin in Young Patients With Cancer

Completed · Not applicable

Conditions studied: Unspecified Childhood Solid Tumor, Protocol Specific

In brief

This laboratory study is looking at the pharmacokinetics of daunorubicin in young patients with cancer. Collecting and storing samples of blood from patients with cancer to study in the laboratory may help doctors learn more about how patients respond to treatment with certain chemotherapy drugs.

Key facts

Study ID
NCT00673257
Run by
Children's Oncology Group
People needed
107
Starts
2007-01-01
Expected to finish
2020-03-31
Last updated by the study team
2020-04-14

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.